High Tower Advisors, LLC Myriad Genetics Inc Transaction History

High Tower Advisors, LLC

$71.6 Billion
Q4 2024

A detailed history of High Tower Advisors, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 14,477 shares of MYGN stock, worth $210,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,477

Previous 18,027 19.69%

Holding current value

$210,929

Previous $493,000 59.84%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$13.17 - $27.03 $46,753 - $95,956	-3,550 Reduced 19.69%	14,477 $198,000
Q3 2024 Nov 14, 2024	SELL	$23.97 - $28.6 $5,513 - $6,578	-230 Reduced 1.26%	18,027 $493,000
Q2 2024 Aug 13, 2024	BUY	$17.98 - $25.47 $59,837 - $84,764	3,328 Added 22.29%	18,257 $446,000
Q1 2024 May 06, 2024	SELL	$17.59 - $23.59 $11,591 - $15,545	-659 Reduced 4.23%	14,929 $318,000
Q4 2023 Feb 12, 2024	BUY	$13.91 - $21.32 $2,448 - $3,752	176 Added 1.14%	15,588 $298,000
Q3 2023 Nov 08, 2023	BUY	$15.99 - $23.22 $5,804 - $8,428	363 Added 2.41%	15,412 $247,000
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $6,356 - $8,601	362 Added 2.46%	15,049 $348,000
Q1 2023 May 11, 2023	SELL	$15.26 - $23.75 $131,464 - $204,606	-8,615 Reduced 36.97%	14,687 $341,000
Q4 2022 Feb 08, 2023	SELL	$14.51 - $20.99 $17,455 - $25,250	-1,203 Reduced 4.91%	23,302 $338,000
Q3 2022 Nov 09, 2022	SELL	$18.21 - $27.88 $3,787 - $5,799	-208 Reduced 0.84%	24,505 $470,000
Q2 2022 Aug 10, 2022	SELL	$16.45 - $25.88 $4,375 - $6,884	-266 Reduced 1.06%	24,713 $452,000
Q1 2022 May 12, 2022	SELL	$22.67 - $28.01 $6,460 - $7,982	-285 Reduced 1.13%	24,979 $630,000
Q4 2021 Feb 10, 2022	BUY	$24.13 - $32.63 $10,448 - $14,128	433 Added 1.74%	25,264 $700,000
Q3 2021 Nov 12, 2021	BUY	$29.97 - $36.66 $4,705 - $5,755	157 Added 0.64%	24,831 $799,000
Q2 2021 Aug 06, 2021	SELL	$25.39 - $32.61 $60,986 - $78,329	-2,402 Reduced 8.87%	24,674 $755,000
Q1 2021 May 10, 2021	BUY	$19.92 - $31.6 $6,175 - $9,796	310 Added 1.16%	27,076 $822,000
Q4 2020 Feb 10, 2021	BUY	$12.16 - $19.77 $14,105 - $22,933	1,160 Added 4.53%	26,766 $528,000
Q3 2020 Nov 13, 2020	SELL	$11.25 - $14.75 $573 - $752	-51 Reduced 0.2%	25,606 $331,000
Q2 2020 Aug 10, 2020	BUY	$10.69 - $16.49 $48,072 - $74,155	4,497 Added 21.25%	25,657 $286,000
Q1 2020 May 21, 2020	BUY	$9.78 - $29.53 $85,193 - $257,235	8,711 Added 69.97%	21,160 $304,000
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $260,557 - $436,959	12,449 New	12,449 $339,000
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $808,622 - $1.35 Million	-29,696 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$37.57 - $50.34 $1.12 Million - $1.49 Million	29,696 New	29,696 $1.36 Million

Others Institutions Holding MYGN

# of Institutions

227

Shares Held

92M

Call Options Held

297K

Put Options Held

20.7K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.17B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Account

High Tower Advisors, LLC Myriad Genetics Inc Transaction History